Investigation of the mechanisms of response and resistance of neratinib +/- hormone treatment in breast cancer cells which moderately expressing HER2

  • Kong, Anthony (Principal Investigator)

Project Details

Short titleInvestigation of the mechanisms of response and resistance of neratinib +/- hormone treatment in breast cancer cells which moderately expressing HER2
StatusFinished
Effective start/end date19/07/17 → 1/02/23

Funding

  • PUMA BIOTECHNOLOGY INC